However, it did indicate that a combination of CRP, IL‐6, YKL‐40, CEA and CA 19‐9 can identify a subgroup of patients with nonspecific signs and symptoms of cancer who will develop cancer, and that they have a very poor prognosis if all biomarkers are elevated. This evidence concerns the gene CHI3L1 and cancer.